Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Equipment Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Gene Expression Analysis Market, by Product
6.1 Introduction
6.2 Consumables
6.2.1 Reagents
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
6.2.2 DNA Chips
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
6.3 Instruments
6.3.1 Polymerase Chain Reaction (PCR)
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
6.3.2 Next Generation Sequencing (NGS)
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
6.3.3 Microarray
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
6.3.4 Sanger Sequencing
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
6.3.3 Others
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
Chapter 7. Global Gene Expression Analysis Market, by Services
7.1 Introduction
7.2 Gene Expression Profiling Services
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
7.3 Sequencing Services
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
7.4 Bioinformatics Solutions
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
7.5 Others
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
Chapter 8. Global Gene Expression Analysis Market, by Application
8.1 Introduction
8.2 Drug Discovery
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
8.3 Diagnosis
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
8.4 Research
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
8.5 Others
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
Chapter 9. Global Gene Expression Analysis Market, by End User
9.1 Introduction
9.2 Pharmaceutical & Biotechnology Companies
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
9.3 Academic & Research Institutes
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
9.4 Contract Research Organizations
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
9.5 Others
Market Estimates & Forecast, by Region, 2023–2032
Market Estimates & Forecast, by Country, 2023–2032
Chapter 10. Global Gene Expression Analysis Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 US
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 UK
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia-Pacific
10.5 Middle East & Africa
10.5.1 Middle East
10.5.2 Africa
Chapter 11. Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
Chapter 12. Company Profiles
12.1 General Electric Company
12.1.1 Company Overview
12.1.2 Products Overview
12.1.3 Financials Overview
12.1.4 Key Developments
12.1.5 SWOT Analysis
12.2 Illumina, Inc.
12.2.1 Company Overview
12.2.2 Products Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 Thermo Fisher Scientific
12.3.1 Company Overview
12.3.2 Products Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 Bio-Rad Laboratories, Inc.
12.4.1 Company Overview
12.4.2 Products Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 F. Hoffmann-La Roche Ltd
12.5.1 Company Overview
12.5.2 Products Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.6 Pacific Biosciences of California, Inc.
12.6.1 Company Overview
12.6.2 Products Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.7 BGI
12.7.1 Overview
12.7.2 Products Overview
12.7.3 Financial Overview
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 PerkinElmer Inc.
12.8.1 Overview
12.8.2 Products Overview
12.8.3 Financials
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.9 Agilent Technologies, Inc.
12.9.1 Overview
12.9.2 Products Overview
12.9.3 Financials
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.10 QIAGEN
12.10.1 Overview
12.10.2 Products Overview
12.10.3 Financials
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.11 Oxford Gene Technology
12.11.1 Company Overview
12.11.2 Products Overview
12.11.3 Financial Overview
12.11.4 Key Developments
12.11.5 SWOT Analysis
12.12 Eurofins Scientific
12.12.1 Overview
12.12.2 Products Overview
12.12.3 Financial Overview
12.12.4 Key Developments
12.12.5 SWOT Analysis
12.13 Danaher
12.13.1 Overview
12.13.2 Products Overview
12.13.3 Financials
12.13.4 Key Developments
12.13.5 SWOT Analysis
12.14 Genotypic Technology Pvt Ltd
12.14.1 Overview
12.14.2 Products Overview
12.14.3 Financials
12.14.4 Key Developments
12.14.5 SWOT Analysis
12.15 Macrogen Inc.
12.15.1 Overview
12.15.2 Products Overview
12.15.3 Financials
12.15.4 Key Developments
12.15.5 SWOT Analysis
Chapter 13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEO’s Viewpoint
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Predictions for the Gene Expression Analysis Industry
Chapter 14. Appendix
LIST OF TABLES
Table 1 Global Gene Expression Analysis Market Synopsis, 2023–2032
Table 2 Global Gene Expression Analysis Market Estimates and Forecast, 2023–2032 (USD Billion)
Table 3 Global Gene Expression Analysis Market, by Region, 2023–2032 (USD Billion)
Table 4 Global Gene Expression Analysis Market, by Product, 2023–2032 (USD Billion)
Table 5 Global Gene Expression Analysis Market, by Services, 2023–2032 (USD Billion)
Table 6 Global Gene Expression Analysis Market, by Applications, 2023–2032 (USD Billion)
Table 7 Global Gene Expression Analysis Market, by End User, 2023–2032 (USD Billion)
Table 8 North America: Gene Expression Analysis Market, by Product, 2023–2032 (USD Billion)
Table 9 North America: Gene Expression Analysis Market, by Services, 2023–2032 (USD Billion)
Table 10 North America: Gene Expression Analysis Market, by Applications, 2023–2032 (USD Billion)
Table 11 North America: Gene Expression Analysis Market, by End User, 2023–2032 (USD Billion)
Table 12 US: Gene Expression Analysis Market, by Product, 2023–2032 (USD Billion)
Table 13 US: Gene Expression Analysis Market, by Services, 2023–2032 (USD Billion)
Table 14 US: Gene Expression Analysis Market, by Applications, 2023–2032 (USD Billion)
Table 15 US: Gene Expression Analysis Market, by End User, 2023–2032 (USD Billion)
Table 16 Canada: Gene Expression Analysis Market, by Product, 2023–2032 (USD Billion)
Table 17 Canada: Gene Expression Analysis Market, by Services, 2023–2032 (USD Billion)
Table 18 Canada: Gene Expression Analysis Market, by Applications, 2023–2032 (USD Billion)
Table 19 Canada: Gene Expression Analysis Market, by End User, 2023–2032 (USD Billion)
Table 20 South America: Gene Expression Analysis Market, by Product, 2023–2032 (USD Billion)
Table 21 South America: Gene Expression Analysis Market, by Services, 2023–2032 (USD Billion)
Table 22 South America: Gene Expression Analysis Market, by Applications, 2023–2032 (USD Billion)
Table 23 South America: Gene Expression Analysis Market, by End User, 2023–2032 (USD Billion)
Table 24 Europe: Gene Expression Analysis Market, by Product, 2023–2032 (USD Billion)
Table 25 Europe: Gene Expression Analysis Market, by Services, 2023–2032 (USD Billion)
Table 26 Europe: Gene Expression Analysis Market, by Applications, 2023–2032 (USD Billion)
Table 27 Europe: Gene Expression Analysis Market, by End User, 2023–2032 (USD Billion)
Table 28 Western Europe: Gene Expression Analysis Market, by Product, 2023–2032 (USD Billion)
Table 29 Western Europe: Gene Expression Analysis Market, by Services, 2023–2032 (USD Billion)
Table 30 Western Europe: Gene Expression Analysis Market, by Applications, 2023–2032 (USD Billion)
Table 31 Western Europe: Gene Expression Analysis Market, by End User, 2023–2032 (USD Billion)
Table 32 Eastern Europe: Gene Expression Analysis Market, by Product, 2023–2032 (USD Billion) Table 33 Eastern Europe: Gene Expression Analysis Market, by Services, 2023–2032 (USD Billion)
Table 34 Eastern Europe: Gene Expression Analysis Market, by Applications, 2023–2032 (USD Billion)
Table 35 Eastern Europe: Gene Expression Analysis Market, by End User, 2023–2032 (USD Billion)
Table 36 Asia-Pacific: Gene Expression Analysis Market, by Product, 2023–2032 (USD Billion) Table 37 Asia-Pacific: Gene Expression Analysis Market, by Services, 2023–2032 (USD Billion)
Table 38 Asia-Pacific: Gene Expression Analysis Market, by Applications, 2023–2032 (USD Billion)
Table 39 Asia-Pacific: Gene Expression Analysis Market, by End User, 2023–2032 (USD Billion)
Table 40 Middle East & Africa: Gene Expression Analysis Market, by Product, 2023–2032 (USD Billion)
Table 41 Middle East & Africa: Gene Expression Analysis Market, by Services, 2023–2032 (USD Billion)
Table 42 Middle East & Africa: Gene Expression Analysis Market, by Applications, 2023–2032 (USD Billion)
Table 43 Middle East & Africa: Gene Expression Analysis Market, by End User, 2023–2032 (USD Billion)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Market Structure for Global Gene Expression Analysis Market
Figure 3 Market Dynamics for Global Gene Expression Analysis Market
Figure 4 Global Gene Expression Analysis Market Share, by Product, 2023
Figure 5 Global Gene Expression Analysis Market Share, by Services, 2023
Figure 6 Global Gene Expression Analysis Market Share, by Applications, 2023
Figure 7 Global Gene Expression Analysis Market Share, by End User, 2023
Figure 8 Global Gene Expression Analysis Market Share, by Region, 2023
Figure 9 North America: Gene Expression Analysis Market Share, by Country, 2023
Figure 10 Europe: Gene Expression Analysis Market Share, by Country, 2023
Figure 11 Asia-Pacific: Gene Expression Analysis Market Share, by Country, 2023
Figure 12 Middle East & Africa: Gene Expression Analysis Market Share, by Country, 2023
Figure 13 Global Gene Expression Analysis Market: Company Share Analysis, 2023 (%)
Figure 14 GENERAL ELECTRIC COMPANY: Key Financials
Figure 15 GENERAL ELECTRIC COMPANY: Segmental Revenue
Figure 16 GENERAL ELECTRIC COMPANY: Geographical Revenue
Figure 17 Illumina, Inc.: Key Financials
Figure 18 Illumina, Inc.: Segmental Revenue
Figure 19 Illumina, Inc.: Geographical Revenue
Figure 20 THERMO FISHER SCIENTIFIC: Key Financials
Figure 21 THERMO FISHER SCIENTIFIC: Segmental Revenue
Figure 22 THERMO FISHER SCIENTIFIC: Geographical Revenue
Figure 23 Bio-Rad Laboratories, Inc.: Key Financials
Figure 24 Bio-Rad Laboratories, Inc.: Segmental Revenue
Figure 25 Bio-Rad Laboratories, Inc.: Geographical Revenue
Figure 26 F. Hoffmann-La Roche Ltd: Key Financials
Figure 27 F. Hoffmann-La Roche Ltd: Segmental Revenue
Figure 28 F. Hoffmann-La Roche Ltd: Geographical Revenue
Figure 29 Pacific Biosciences of California, Inc.: Key Financials
Figure 30 Pacific Biosciences of California, Inc.: Segmental Revenue
Figure 31 Pacific Biosciences of California, Inc.: Geographical Revenue
Figure 32 BGI: Key Financials
Figure 33 BGI: Segmental Revenue
Figure 34 BGI: Geographical Revenue
Figure 35 PerkinElmer Inc.: Key Financials
Figure 36 PerkinElmer Inc.: Segmental Revenue
Figure 37 PerkinElmer Inc.: Geographical Revenue
Figure 38 Agilent Technologies, Inc.: Key Financials
Figure 39 Agilent Technologies, Inc.: Segmental Revenue
Figure 40 Agilent Technologies, Inc.: Geographical Revenue
Figure 41 QIAGEN: Key Financials
Figure 42 QIAGEN: Segmental Revenue
Figure 43 QIAGEN: Geographical Revenue
Figure 44 Oxford Gene Technology: Key Financials
Figure 45 Oxford Gene Technology: Segmental Revenue
Figure 46 Oxford Gene Technology: Geographical Revenue
Figure 47 Eurofins Scientific: Key Financials
Figure 48 Eurofins Scientific: Segmental Revenue
Figure 49 Eurofins Scientific: Geographical Revenue
Figure 50 Danaher: Key Financials
Figure 51 Danaher: Segmental Revenue
Figure 52 Danaher: Geographical Revenue
Figure 53 Genotypic Technology Pvt Ltd: Key Financials
Figure 54 Genotypic Technology Pvt Ltd: Segmental Revenue
Figure 55 Genotypic Technology Pvt Ltd: Geographical Revenue
Figure 56 Macrogen Inc.: Key Financials
Figure 57 Macrogen Inc.: Segmental Revenue
Figure 58 Macrogen Inc.: Geographical Revenue
